PointofLaw.com
 Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  
   
 
   

 

 

Pharma "litigation for all, and safety for none"



Paul Howard of the Manhattan Institute's Center for Medical Progress warns against the efforts of some in Congress to use a pending federal drug-regulation bill to curtail pre-emption and thus expand the scope of tort liability.

 

 


Rafael Mangual
Project Manager,
Legal Policy
rmangual@manhattan-institute.org

Katherine Lazarski
Manhattan Institute
klazarski@manhattan-institute.org

 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.